{
  "trial_id": "NCT02361541",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adult (> or = 18 years old)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Documented HIV positive",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "In regular HIV care follow-up (min. 2 consultations in the last six months prior to the study)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Willing and able to provide written informed consent",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "HIV patients with currently taking Hepatitis C treatment or with a history of prior hepatitis C treatment",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient is on IFN (100 mg/week) plus RBV (400 mg/day) combination therapy for the past 9 months, but direct antiviral drugs were added to his treatment 6 months ago.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT02361541",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}